The prognostic value of plasma thrombospondin-1 concentrations after aneurysmal subarachnoid hemorrhage

Clinica Chimica Acta

Volumn 448, Issue , 2015, Pages 155-160

  Shen, Yong Feng ^a   Wang, Wen Hong ^b   Yu, Wen Hua ^c   Dong, Xiao Qiao ^c   Du, Quan ^c   Yang, Ding Bo ^a   Wang, Hao ^c   Jiang, Li ^c   Du, Yuan Feng ^c   Zhang, Zu Yong ^c   Zhu, Qiang ^c   Che, Zhi Hao ^c   Liu, Qun Jie ^a  

^a Hospital of Hangzhou City Zhejiang   (China)

^b AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Intracranial aneurysmal; Prognosis; Severity; Subarachnoid hemorrhage; Thrombospondin 1

Indexed keywords

THROMBOSPONDIN 1;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY ASSESSMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FISHER SCORE; FOLLOW UP; GLASGOW OUTCOME SCALE; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE; WORLD FEDERATION OF NEUROLOGICAL SURGEON SCORE; BLOOD; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SUBARACHNOID HEMORRHAGE; THROMBOSPONDIN 1;

EID: 84936996841     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.06.024     Document Type: Article

References (45)

1. de Rooij N.K., Linn F.H., van der Plas J.A., Algra A., Rinkel G.J. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J. Neurol. Neurosurg. Psychiatry 2007, 78:1365-1372.
2. Feigin V.L., Lawes C.M., Bennett D.A., Barker-Collo S.L., Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009, 8:355-369.
3. Hanafy K.A., Morgan Stuart R., Fernandez L., et al. Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage. J. Clin. Neurosci. 2010, 17:22-25.
4. Dhar R., Diringer M.N. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit. Care. 2008, 8:404-412.
5. Le Roux P.D., Elliott J.P., Newell D.W., Grady M.S., Winn H.R. Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J. Neurosurg. 1996, 85:39-49.
6. Frijns C.J., Fijnheer R., Algra A., van Mourik J.A., van Gijn J., Rinkel G.J. Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome. J. Neurol. Neurosurg. Psychiatry 2006, 77:77-83.
7. Khurana V.G., Wijdicks E.F., Heubline D.M., McClellnd R.L., Meyer F.B., Piepgras D.G., et al. A pilot study of Dendroaspis natriuretic peptide in aneurysmal subarachnoid hemorrhage. Neurosurgery 2004, 55:69-76.
8. Baezinger NL B.G., Majerus P.W. Isolation and properties of a thrombin-sensitive protein of human platelets. J. Biol. Chem. 1972, 247:2723-2731.
9. McLaren K.M. Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. J. Clin. Pathol. 1983, 36:197-199.
10. Lawler J. The structural and functional properties of thrombospondin. Blood 1986, 67:1197-1209.
11. Mosher D.F., Doyle M.J., Jaffe E.A. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J. Cell Biol. 1982, 93:343-348.
12. Bonnefoy A., Moura R., Hoylaerts M.F. The evolving role of thrombospondin-1 in hemostasis and vascular biology. Cell. Mol. Life Sci. 2008, 65:713-727.
13. Lawler P.R., Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb. Perspect. Med. 2012, 2:a006627.
14. Starlinger P., Moll H.P., Assinger A., et al. Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. J. Thromb. Haemost. 2010, 8:1809-1819.
15. Rico M.C., Manns J.M., Driban J.B., Uknis A.B., Kunapuli S.P., Dela Cadena R.A. Thrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritis. Transl. Res. 2008, 152:95-98.
16. Xu J., Xiao N., Xia J. Thrombospondin 1 accelerates synaptogenesis in hippocampal neurons through neuroligin 1. Nat. Neurosci. 2010, 13:22-24.
17. Christopherson K.S., Ullian E.M., Stokes C.C., et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005, 120:421-433.
18. Chen J.K., Zhan Y.J., Yang C.S., Tzeng S.F. Oxidative stress-induced attenuation of thrombospondin-1 expression in primary rat astrocytes. J. Cell. Biochem. 2011, 112:59-70.
19. Scott-Drew S. ffrench-Constant C. Expression and function of thrombospondin-1 in myelinating glial cells of the central nervous system. J. Neurosci. Res. 1997, 50:202-214.
20. Lin T.N., Kim G.M., Chen J.J., Cheung W.M., He Y.Y., Hsu C.Y. Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion. Stroke 2003, 34:177-186.
21. Yang A.L., Zhou H.J., Lin Y., et al. Thrombin promotes the expression of thrombospondin-1 and -2 in a rat model of intracerebral hemorrhage. J. Neurol. Sci. 2012, 323:141-146.
22. Tran M.D., Furones-Alonso O., Sanchez-Molano J., Bramlett H.M. Trauma-induced expression of astrocytic thrombospondin-1 is regulated by P2 receptors coupled to protein kinase cascades. Neuroreport 2012, 23:721-726.
23. Wang X., Chen W., Liu W., Wu J., Shao Y., Zhang X. The role of thrombospondin-1 and transforming growth factor-beta after spinal cord injury in the rat. J. Clin. Neurosci. 2009, 16:818-821.
24. Choi K.Y., Kim D.B., Kim M.J., et al. Higher plasma thrombospondin-1 levels in patients with coronary artery disease and diabetes mellitus. Korean Circ. J. 2012, 42:100-106.
25. Novelli E.M., Kato G.J., Ragni M.V., et al. Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates. Am. J. Hematol. 2012, 87:326-330.
26. Starlinger P., Haegele S., Wanek D., et al. Plasma thrombospondin 1 as a predictor of postoperative liver dysfunction. Br. J. Surg. 2015, 102:826-836.
27. Drake C. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J. Neurosurg. 1988, 68:985-986.
28. Liauw J., Hoang S., Choi M., et al. Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J. Cereb. Blood Flow Metab. 2008, 28:1722-1732.
29. Yonezawa T., Hattori S., Inagaki J., et al. Type IV collagen induces expression of thrombospondin-1 that is mediated by integrin alpha1beta1 in astrocytes. Glia 2010, 58:755-767.
30. Tran M.D., Neary J.T. Purinergic signaling induces thrombospondin-1 expression in astrocytes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:9321-9326.
31. Zadeh G., Guha A. Angiogenesis in nervous system disorders. Neurosurgery 2003, 53:1362-1374.
32. Good D.J., Polverini P.J., Rastinejad F., et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:6624-6628.
33. Kyriakides T.R., Maclauchlan S. The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J. Cell Commun. Signal 2009, 3:215-225.
34. Bornstein P. Thrombospondins function as regulators of angiogenesis. J. Cell Commun. Signal 2009, 3:189-200.
35. Tolsma S.S., Volpert O.V., Good D.J., Frazier W.A., Polverini P.J., Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 1993, 122:497-511.
36. Suzuma K., Takagi H., Otani A., Oh H., Honda Y. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. Am. J. Pathol. 1999, 154:343-354.
37. Zhou H.J., Zhang H.N., Tang T., et al. Alteration of thrombospondin-1 and -2 in rat brains following experimental intracerebral hemorrhage. Laboratory investigation. J. Neurosurg. 2010, 113:820-825.
38. Yu K., Ge J., Summers J.B., et al. TSP-1 secreted by bone marrow stromal cells contributes to retinal ganglion cell neurite outgrowth and survival. PLoS One 2008, 3.
39. Du Q., Yu W.H., Dong X.Q., et al. Plasma 8-iso-prostaglandin F2α concentrations and outcomes after acute intracerebral hemorrhage. Clin. Chim. Acta 2014, 437:141-146.
40. Cai J.Y., Chen X.D., Ba H.J., et al. Identification of plasma adrenomedullin as a possible prognostic biomarker for aneurysmal subarachnoid hemorrhage. Peptides 2014, 59:9-13.
41. Chen T.J., Fu Q.Y., Wu W.Q. Plasma levels of adrenomedullin in patients with traumatic brain injury: potential contribution to prognosis. Peptides 2014, 56:146-150.
42. Shen L.J., Yang S.B., Lv Q.W., et al. High plasma adiponectin levels in patients with severe traumatic brain injury. Clin. Chim. Acta 2014, 427:37-41.
43. Badjatia N., Monahan A., Carpenter A., et al. Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage. Neurology 2015, 84:680-687.
44. Frontera J.A., Aledort L., Gordon E., et al. Early platelet activation, inflammation and acute brain injury after a subarachnoid hemorrhage: a pilot study. J. Thromb. Haemost. 2012, 10:711-713.
45. Juvela S., Siironen J. D-dimer as an independent predictor for poor outcome after aneurysmal subarachnoid hemorrhage. Stroke 2006, 37:1451-1456.